Cardiomyocytes from 15-day-old fetal hamsters with hereditary cardiomyopathy showed increased intracellular calcium, sodium, ROS, and NHE-1 compared to normal hamsters.
Background/objectives: The development of hereditary cardiomyopathy associated with early death was known to take place during the patients’ lifetime. Previous work showed that remodeling of heart cells in hereditary cardiomyopathy of hamsters (HCMH) took place as early as during postnatal development. The present work tested the hypothesis that cardiomyocyte remodeling in HCMH occurred early in fetal development. Methods and results: Using quantitative 3D confocal microscopy associated with ionic and immunofluorescence, our results showed that, as in the adult heart, cardiomyocytes isolated from 15-day-old fetal HCMH hearts showed an increase in intracellular calcium, sodium, ROS, and sodium-hydrogen exchanger 1 (NHE-1) when compared to age-matched cardiomyocytes of a normal hamster (NH). Conclusions: These results demonstrated that hereditary cardiomyopathy occurred during fetal heart development, and that early treatment with an NHE-1 blocker might have prevented the development of hereditary cardiomyopathy and heart failure that occur during the hamsters’ lifetime.
Bkaily et al. (Mon,) conducted a other in Hereditary cardiomyopathy. Hereditary cardiomyopathy of hamsters (HCMH) vs. Age-matched normal hamster (NH) was evaluated on Intracellular calcium, sodium, ROS, and sodium-hydrogen exchanger 1 (NHE-1) levels. Cardiomyocytes from 15-day-old fetal hamsters with hereditary cardiomyopathy showed increased intracellular calcium, sodium, ROS, and NHE-1 compared to normal hamsters.